Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.74 |
| ▸ | LMNA | P02545 | 1/20 | 0.74 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.74 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | MGAM | O43451 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | SI | P14410 | 1/20 | 0.42 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.42 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.42 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 2/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CA9 | Q16790 | 2/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.39 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | PGR | P06401 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethyl Acetate SCHEMBL27685753 | 0.89 | ALDH1A1 (0.82) | ALDH1A1LMNAHSD17B10TSHRALOX15 | |
| Ethyl Acetate SCHEMBL2224760 | 0.89 | ALDH1A1 (0.58) | ALDH1A1LMNAHSD17B10TSHRALOX15 | |
| Ethyl Acetate SCHEMBL28111892 | 0.87 | ALDH1A1 (0.70) | ALDH1A1LMNAHSD17B10TSHRALOX15 | |
| Ethyl Acetate SCHEMBL11138572 | 0.86 | ALDH1A1 (0.78) | ALDH1A1LMNAHSD17B10TSHRALOX15 | |
| Ethyl Acetate SCHEMBL28457765 | 0.86 | ALDH1A1 (1.00) | ALDH1A1LMNAHSD17B10TSHRALOX15 | |
| Ethyl Acetate SCHEMBL28615209 | 0.86 | ALDH1A1 (1.00) | ALDH1A1LMNAHSD17B10TSHRALOX15 | |
| Ethyl Acetate SCHEMBL30152067 | 0.86 | — | — | |
| Ethyl Acetate SCHEMBL1331901 | 0.86 | — | — | |
| Ethyl Acetate SCHEMBL1331990 | 0.86 | — | — | |
| Ethyl Acetate SCHEMBL70316 | 0.86 | ALDH1A1 (1.00) | ALDH1A1LMNAHSD17B10TSHRALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011033307-A1 | NILOTINIB DIHYDROCHLORIDE SALT | GENERICS [UK] LIMITED (GB) | 2011-03-24 | — | — | WO | claimed |
| US-11834388-B2 | Continuous-flow preparation method of diclofenac sodium | FUDAN UNIVERSITY (CN) | 2023-12-05 | — | — | US | disclosed |
| US-20230192595-A1 | CONTINUOUS-FLOW PREPARATION METHOD OF DICLOFENAC SODIUM | FUDAN UNIVERSITY (CN) | 2023-06-22 | — | — | US | disclosed |
| US-10065969-B2 | Method for producing carboxylic acid anhydride, method for producing carboxylic imide, and method for manufacturing electrophotographic photosensitive member | CANON KABUSHIKI KAISHA (JP) | 2018-09-04 | — | — | US | disclosed |
| US-20160376285-A1 | METHOD FOR PRODUCING CARBOXYLIC ACID ANHYDRIDE, METHOD FOR PRODUCING CARBOXYLIC IMIDE, AND METHOD FOR MANUFACTURING ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER | CANON KABUSHIKI KAISHA (JP) | 2016-12-29 | — | — | US | disclosed |
| US-9260438-B2 | Solid forms of tofacitinib salts | APOTEX INC. (CA) | 2016-02-16 | — | — | US | disclosed |
| US-20150225406-A1 | SOLID FORMS OF TOFACITINIB SALTS | APOTEX INC. (CA) | 2015-08-13 | — | — | US | disclosed |
| US-20150175812-A1 | ANTIMICROBIAL COATINGS | 3M INNOVATIVE PROPERTIES CO (US) | 2015-06-25 | — | — | US | disclosed |
| WO-2011033307-A1 | NILOTINIB DIHYDROCHLORIDE SALT | GENERICS [UK] LIMITED (GB) | 2011-03-24 | — | — | WO | disclosed |
| EP-0884311-A2 | Triazole Derivatives and their production | Takeda Chemical Industries, Ltd. (JP) | 1998-12-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10065969-B2 | Method for producing carboxylic acid anhydride, method for producing carboxylic imide, and method for manufacturing electrophotographic photosensitive member | CA7, CA4, CA6 | ALDH1A1 121/4885LMNA 3752/4885HSD17B10 632/4885 |
| US-20230192595-A1 | CONTINUOUS-FLOW PREPARATION METHOD OF DICLOFENAC SODIUM | SULT2A1, NIT2, CA2 | ALDH1A1 139/4885LMNA 3103/4885HSD17B10 3193/4885 |
| US-20160376285-A1 | METHOD FOR PRODUCING CARBOXYLIC ACID ANHYDRIDE, METHOD FOR PRODUCING CARBOXYLIC IMIDE, AND METHOD FOR MANUFACTURING ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER | CA7, CA4, CA6 | ALDH1A1 121/4885LMNA 3752/4885HSD17B10 632/4885 |
| US-11834388-B2 | Continuous-flow preparation method of diclofenac sodium | SULT2A1, NIT2, CA2 | ALDH1A1 131/4885LMNA 2864/4885HSD17B10 3290/4885 |
| US-20150225406-A1 | SOLID FORMS OF TOFACITINIB SALTS | JAK3, JAK2, JAK1 | ALDH1A1 4512/4885LMNA 3743/4885HSD17B10 3201/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.